- Home
- CADL vs DMRC Comparison
CADL vs DMRC Comparison
Compare CADL & DMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- DMRC
- Stock Information
- Founded
- CADL 1999
- DMRC 2008
- Country
- CADL United States
- DMRC United States
- Employees
- CADL N/A
- DMRC N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- DMRC EDP Services
- Sector
- CADL Health Care
- DMRC Technology
- Exchange
- CADL Nasdaq
- DMRC Nasdaq
- Market Cap
- CADL 278.6M
- DMRC 260.3M
- IPO Year
- CADL 2021
- DMRC N/A
- Fundamental
- Price
- CADL $5.95
- DMRC $8.81
- Analyst Decision
- CADL Strong Buy
- DMRC Strong Buy
- Analyst Count
- CADL 5
- DMRC 1
- Target Price
- CADL $21.40
- DMRC $30.00
- AVG Volume (30 Days)
- CADL 627.9K
- DMRC 225.9K
- Earning Date
- CADL 08-14-2025
- DMRC 08-14-2025
- Dividend Yield
- CADL N/A
- DMRC N/A
- EPS Growth
- CADL N/A
- DMRC N/A
- EPS
- CADL N/A
- DMRC N/A
- Revenue
- CADL N/A
- DMRC $35,479,000.00
- Revenue This Year
- CADL N/A
- DMRC N/A
- Revenue Next Year
- CADL N/A
- DMRC $4.21
- P/E Ratio
- CADL N/A
- DMRC N/A
- Revenue Growth
- CADL N/A
- DMRC N/A
- 52 Week Low
- CADL $3.79
- DMRC $7.83
- 52 Week High
- CADL $14.60
- DMRC $48.32
- Technical
- Relative Strength Index (RSI)
- CADL 47.68
- DMRC 32.59
- Support Level
- CADL $5.45
- DMRC $7.93
- Resistance Level
- CADL $6.16
- DMRC $11.93
- Average True Range (ATR)
- CADL 0.32
- DMRC 0.80
- MACD
- CADL -0.07
- DMRC -0.27
- Stochastic Oscillator
- CADL 48.54
- DMRC 19.92
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About DMRC Digimarc Corporation
Digimarc Corp is engaged in digital watermarking technologies. The Digimarc Illuminate platform is a distinctive software as a service (SaaS) cloud-based platform for digital connectivity that provides the tools for the application of digital watermarks and dynamic Quick Response (QR) codes, software (digital twins) that enables various systems and devices to interact with those data carriers and a centralized platform for capturing insights about digital interactions and automating activities based on that information. The company generates revenue through commercial and government applications of its technology. The company derives its revenue from software development services, subscriptions for products and related services, and licensing of patents.